Oncology-Based In-Vivo CRO Market Demand Analysis: 2033 fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.
The global oncology-based in-vivo CRO market is worth US$ 1.1 Billion as of now and is expected to reach US$ 2.9 Billion by the year 2033 at a notable CAGR of 10.9% between 2023 and 2033.The WHO states that as of the year 2020, 19.3 Million novel cases of cancer were reported along with 10 Million fatalities. This a.
The Bar Harbor institution was awarded over $140 million in grant funds during 2021, a new annual record for the biomedical research institute. The lab also saw other milestones during the year, including the start of a new CEO.
With an eye toward possible expansion of The Jackson Laboratory for Genomic Medicine in Farmington, new spinoffs and possibly new hires down the road, longtime researcher and academic Dr. Lon Cardon will take the helm as president and CEO of the seven-year-old growing facility on Nov. 29.
The 56-year-old Cardon who is currently the chief science strategic officer of California-based BioMarin Pharmaceutical Inc. will replace current president and CEO Dr. Edison Liu.
JAX announces Japan lab acquisition - Mount Desert Islander mdislander.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mdislander.com Daily Mail and Mail on Sunday newspapers.